Aquestive Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-82.1M | $28.0M |
| FY2022 | $33.4M | $-118.6M | $27.3M |
| FY2023 | $45.0M | $-106.5M | $23.9M |
| FY2024 | $45.0M | $-60.2M | $71.5M |
| FY2025 | $45.0M | $-33.7M | $121.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-82.1M | $28.0M |
| FY2022 | $33.4M | $-118.6M | $27.3M |
| FY2023 | $45.0M | $-106.5M | $23.9M |
| FY2024 | $45.0M | $-60.2M | $71.5M |
| FY2025 | $45.0M | $-33.7M | $121.2M |